NPPB and cancer: NT-proBNP levels above 600 ng/L were predicted based on the location of the cancer. The intercept of the model was 0.405, corresponding to an odds ratio of 1.5 (95% CI: 0.2506-8.98), with a p-value of 0.657, indicating no significant effect at baseline.